Proton versus photon therapy for esophageal cancer – A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer

• Mortensen, H.R.
• Populaire, P.
• Hoffmann, L.
• Moeller, D.S.
• Appelt, A. https://orcid.org/0000-0003-2792-9218
• Nafteux, P.
• Muijs, C.T.
• Grau, C.
• Hawkins, M.A.
• Troost, E.G.C.
• Defraene, G.
• Canters, R.
• Clarke, C.S.
• Weber, D.C.
• Korevaar, E.W.
• Haustermans, K.
• Nordsmark, M.
• Gebski, V.
• Achiam, M.P.
• Markar, S.R.
• Radhakrishna, G.
• Berbee, M.
• Scartoni, D.
• Orlandi, E.
• Doyen, J.
• Gregoire, V.
• Crehange, G.
• Langendijk, J.
• Lorgelly, P.
• Blommenstein, H.M.
• Byskov, C.S.
• Ehmsen, M.L.
• Jensen, M.F.
• Freixas, G.V.
• Bütoft, R.
• The PROTECT consortium

© 2023 Elsevier B.V. This is an author produced version of an article published in Radiotherapy and Oncology. Uploaded in accordance with the publisher's self-archiving policy.

• Published: January 2024
• Published (online): 5 November 2023
• Accepted: 29 October 2023

• PubMed URL